25 Top Ranked Socially Responsible Dividend Stocks
By The Online Investor Staff, updated Sat., Apr. 20, 1:30 AM
This Slide: #3 of 25 |
#23. Gilead Sciences Inc (NASDAQ:GILD) — 4.66% Yield
Gilead Sciences is a biopharmaceutical company, focusing on medicines to prevent and treat diseases, including HIV, viral hepatitis and cancer. Co.'s products include: Biktarvy®, which is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), an injection for intravenous use, which is a nucleotide analog RNA polymerase inhibitor indicated for certain patients for the treatment of COVID-19 requiring hospitalization; and Epclusa®, which is an oral formulation of a once-daily single tablet regimen of sofosbuvir and velpatasvir for the treatment of chronic hepatitis C virus (HCV) infection in adults and certain pediatric patients.
Gilead Sciences SEC Filing Email Alerts Service
Open the GILD Page at The Online Investor »
|
Open the GILD Page at The Online Investor (in a new window) »
Free GILD Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.83 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: GILD Stock Forecast Based on Zacks ABR data; powered by Xignite |